Correlation Between Cannara Biotech and Brookfield

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Brookfield at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Brookfield into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and Brookfield, you can compare the effects of market volatilities on Cannara Biotech and Brookfield and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Brookfield. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Brookfield.

Diversification Opportunities for Cannara Biotech and Brookfield

0.53

Correlation Coefficient

Cannara Biotech  Brookfield

Very weak diversification

The 3 months correlation between Cannara and Brookfield is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Brookfield in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brookfield and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Brookfield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brookfield has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Brookfield go up and down completely randomly.

Pair Corralation between Cannara Biotech and Brookfield

Assuming the 90 days trading horizon Cannara Biotech is expected to under-perform the Brookfield. In addition to that, Cannara Biotech is 9.52 times more volatile than Brookfield. It trades about -0.01 of its total potential returns per unit of risk. Brookfield is currently generating about 0.26 per unit of volatility. If you would invest  2,351  in Brookfield on September 25, 2024 and sell it today you would earn a total of  99.00  from holding Brookfield or generate 4.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.45%
Values	Daily Returns

Cannara Biotech  vs.  Brookfield

Cannara Biotech

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Brookfield

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Brookfield are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Brookfield may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Cannara Biotech and Brookfield

The main advantage of trading using opposite Cannara Biotech and Brookfield positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Brookfield can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brookfield will offset losses from the drop in Brookfield's long position.

The idea behind Cannara Biotech and Brookfield pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.